Physicians need to weigh risks and benefits of drug prescribing to pregnant patients, based on the available knowledge. The focus on the benefits of drug use for conditions that may have negative pregnancy outcomes when untreated is essential to enable well-founded decisions regarding the use of medicines.
One such drug is aspirin.Previous trials with low-dose aspirin have suggested reduced incidence of preeclampsia, IUGR which was not confirmed by the large CLASP trial. As per the 2010 NICE guidelines, 75mg of aspirin should be taken daily from 12 weeks of gestation onwards in women with: PIH in previous pregnancy Diabetes Hypertension Chronic kidney disease APLA or SLE Besides these women with: Age >40 years Multiple pregnancy Family history of PIH BMI >35 kg/m2 or more (prior to pregnancy) First pregnancy Interval between two pregnancies is more than 10 years Besides, in recurrent…
